NCT00003638View on ClinicalTrials.gov

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

950

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

January 31, 2007

Study Completion Date

December 31, 2008

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Detox-B adjuvant

BIOLOGICAL

THERATOPE STn-KLH vaccine

BIOLOGICAL

keyhole limpet hemocyanin

DRUG

cyclophosphamide

Trial Locations (1)

AB T6N 1H1

Biomira Inc., Edmonton

All Listed Sponsors
lead

Oncothyreon Canada Inc.

INDUSTRY

NCT00003638 - Vaccine Therapy in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter